We are live on
!
Find out more
Celularity
CELU
CELU
38 hedge funds and large institutions have $232M invested in Celularity in 2022 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
375% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 4
171% more capital invested
Capital invested by funds: $85.6M → $232M (+$146M)
148% more call options, than puts
Call options by funds: $12.7M | Put options by funds: $5.13M
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
58% more funds holding
Funds holding: 24 → 38 (+14)
0.59% more ownership
Funds ownership: 1.35% → 1.95% (+0.59%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
38
Holders Change
+14
Holders Change %
+58.33%
% of All Funds
0.6%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
19
Increased
8
Reduced
5
Closed
4
Calls
$12.7M
Puts
$5.13M
Net Calls
+$7.6M
Net Calls Change
+$1.18M
Top Buyers
| 1 |
SIC
Starr International Company
Zug,
Switzerland
|
+$39.8M |
| 2 |
CVSC
C.V. Starr & Co
New York
|
+$19.9M |
| 3 |
Millennium Management
New York
|
+$2.49M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.48M |
| 5 |
HF
HRT Financial
New York
|
+$377K |
